No Data
No Data
Ladenburg Thalmann Maintains Marinus Pharmaceuticals(MRNS.US) With Buy Rating, Maintains Target Price $4
Ladenburg Thalmann analyst Michael Higgins maintains $Marinus Pharmaceuticals(MRNS.US)$ with a buy rating, and maintains the target price at $4.According to TipRanks data, the analyst has a success ra
Truist Financial Maintains Marinus Pharmaceuticals(MRNS.US) With Buy Rating
Truist Financial analyst Joon Lee maintains $Marinus Pharmaceuticals(MRNS.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 48.3% and a total average return of 23.0%
Express News | Truist Securities Maintains Buy on Marinus Pharma, Maintains $10 Price Target
A Quick Look at Today's Ratings for Marinus Pharmaceuticals(MRNS.US), With a Forecast Between $4 to $11
On Jun 18, major Wall Street analysts update their ratings for $Marinus Pharmaceuticals(MRNS.US)$, with price targets ranging from $4 to $11.JMP Securities analyst Jason Butler maintains with a buy ra
Express News | HC Wainwright & Co. Reiterates Buy on Marinus Pharma, Maintains $11 Price Target
Marinus Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/18/2024 653.42% HC Wainwright & Co. $11 → $11 Reiterates Buy → Buy 05/09/2024 653.42% HC Wainwright & C
No Data